Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
In Good Company with Nicolai Tangen
00:00
Europe's Clinical Trials Challenge
This chapter discusses the declining competitiveness of Europe in the global clinical drug trials arena, particularly in contrast to the fast-paced innovation happening in the US and China. It highlights the bureaucratic hurdles Europe faces that delay clinical trial approvals, emphasizing the impact on patient care and drug development. The chapter also examines the critical need for a supportive environment for biotech innovation and addresses issues surrounding pharmaceutical pricing and antibiotic development.
Transcript
Play full episode
